Robotic ankle tests could sharpen stroke rehab
NCT ID NCT06410989
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study examines how ankle impairments affect walking ability in people who had a stroke at least six months ago. Researchers use a robotic device to measure ankle control and sensation, comparing results with standard walking tests and clinical scales. The goal is to develop more precise ways to track and guide rehabilitation. Healthy adults of similar age also participate to provide a baseline.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better, more precise tools for monitoring and rehabilitating ankle function after stroke.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly improve outcomes. The new metrics may not prove more useful than existing clinical measures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Chronic patients post-stroke and healthy individuals as controls
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria * 40 - 80 years of age, inclusive * Normal hearing and vision, can be corrected * No skin allergies to adhesive material, conductive paste, or silver * Ability to walk \>10m independently on level ground without an assistive device or bracing * Able to understand and give informed consent * Able to understand and speak English Inclusion criteria specific for healthy participants: * No neurological disorders * Absence of pathology that could cause abnormal movements of extremities (e.g., epilepsy, stroke, marked arthritis, chronic pain, musculoskeletal injuries) Inclusion criteria specific for participants post-stroke: * Unilateral, supratentorial ischemic or hemorrhagic stroke ≥ six months prior * Minimum activation against gravity for dorsiflexion and plantarflexion, equivalent to a Manual Muscle Test (MMT) score of ≥ +2 * Self-selected walking speed is less than 1.2 m/s Exclusion criteria * Cognitive limitations that would prevent playing games * Adults unable to consent, pregnant women, children, or prisoners * Infection, wounds, or graft sites on lower limbs * History of sustained non-prescribed drug use or substance abuse (as reported by subject; current nicotine use is allowed) * History of peripheral nerve injury * Severe hip, knee, or ankle arthritis * Recent fracture or osteoporosis (as reported by subject) * Bone or joint instability in the lower limb * Severe pain syndromes affecting any part of the lower limbs * Fixed contractures affecting the lower limbs * Medical (cardiac, renal, hepatic, oncological) or psychiatric disease that would interfere with study procedures * Inability or unwillingness to perform study-required activities * Prior neurosurgical procedures Exclusion criteria specific for healthy participants: \- Any neurological diseases (e.g., stroke, Parkinson's disease or other neurodegenerative disorder, severe dementia, brain injury, spinal cord injury, multiple sclerosis, or cancer of the central nervous system) Exclusion criteria specific for participants post-stroke: * Co-existence of other neurological diseases (e.g., Parkinson's disease or other neurodegenerative disorder, severe dementia, brain injury, spinal cord injury, multiple sclerosis, or cancer of the central nervous system) * Botox (botulinum toxin) injection to lower limbs within the prior 3 months * Significant spasticity or contracture in the lower limbs (Modified Ashworth Scale score of 4) * Severe aphasia * Significant loss of sensation in the lower limbs
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stroke are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Zapping the spine while wearing a robotic ankle: a new way to help kids walk?
- Can a nurse and a neighbor help tame chronic disease?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Two ways to catch a hidden heart rhythm after stroke